Positive results for a bronchiolitis vaccine
Monday, January 30, 2023 Moderna, which developed one of the first messenger RNA vaccines against Covid-19, revealed positive preliminary results last week for a trial of respiratory syncytial virus (RSV), which causes bronchiolitis, in the elderly. . This phase 3 trial is being conducted on 37,000 people aged 60 and over in 22 countries. According … Read more